Thursday, 06 August 2020


BGI gets CFIUS nod to acquire Complete Genomics

31 December 2012 | News | By BioSpectrum Bureau

BGI-Shenzhen (BGI) gets nod from Committee on Foreign Investment in the US (CFIUS) to acquire Complete Genomics

BGI-Shenzhen (BGI) gets nod from Committee on Foreign Investment in the US (CFIUS) to acquire Complete Genomics

Singapore: BGI-Shenzhen (BGI) and Complete Genomics have obtained clearance from the Committee on Foreign Investment in the US (CFIUS) regarding BGI's proposed acquisition of Complete.

The clearance was pursuant to the previously announced agreement and plan of merger, dated September 15, 2012, among BGI, Beta Acquisition and Complete. BGI-Shenzhen had on December 14 extended the acquisition date to December 31, 2012.

BGI's financial advisor is Citi, and its legal counsel is O'Melveny & Myers. Complete's financial adviser is Jefferies & Company, and its legal counsel is Latham & Watkins.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls